Skip to main content

Closed

GALT: Galectin Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

18thpctl

Volume

0.58×avg

Market Cap

195.59MUSD

P/E Ratio

-7.3TTM

Div Yield

-ann

Galectin Therapeutics Inc.

GALTNASDAQ Capital Market·USD·Closed

Galectin Therapeutics Inc.

GALTNASDAQ·USD·Closed

$2.97

−8.05%

$2.97

−$0.26 (8.05%)

52W Range

18thpctl

Volume

0.58×avg

Mkt Cap

195.59MUSD

P/E

-7.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings